APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sepsis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sepsis Drug Industry Growth and Trends Forecast to 2032

2 January 2026106 pages

Choose your research edition.

Industry ResearchSepsis Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Sepsis Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Sepsis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sepsis Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Sepsis Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sepsis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sepsis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sepsis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sepsis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sepsis Drug include TEVA, Johnson & Johnson, Novartis, Mylan, Pfizer, GlaxoSmithKline, Bayer, Shanghai Pharmaceuticals and NCPC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sepsis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sepsis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sepsis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sepsis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sepsis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sepsis Drug Market by Company

TEVA

Johnson & Johnson

Novartis

Mylan

Pfizer

GlaxoSmithKline

Bayer

Shanghai Pharmaceuticals

NCPC

Merck & Co

Allergan

Sepsis Drug Segment by Type

Cephalosporin

Pencillin

Macrolides

Others

Sepsis Drug Segment by Application

Severe Sepsis

Septic Shock

Sepsis

Sepsis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sepsis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sepsis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sepsis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sepsis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sepsis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cephalosporin Table 2. Major Company of Pencillin Table 3. Major Company of Macrolides Table 4. Major Company of Others Table 5. Global Sepsis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Sepsis Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Sepsis Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Sepsis Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Sepsis Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Sepsis Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Sepsis Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Sepsis Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Sepsis Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Sepsis Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Sepsis Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Sepsis Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Sepsis Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Sepsis Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Sepsis Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Sepsis Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Sepsis Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Sepsis Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Sepsis Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Sepsis Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Sepsis Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Sepsis Drug Industry Trends Table 27. Sepsis Drug Industry Drivers Table 28. Sepsis Drug Industry Opportunities and Challenges Table 29. Sepsis Drug Industry Restraints Table 30. Global Sepsis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Sepsis Drug Revenue Market Share by Company (2021-2026) Table 32. Global Sepsis Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Sepsis Drug Sales Share by Company (2021-2026) Table 34. Global Sepsis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Sepsis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Sepsis Drug Major Company Production Sites and Headquarters Table 37. Global Sepsis Drug Company, Product Type & Application Table 38. Global Sepsis Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Sepsis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Sepsis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Sepsis Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Sepsis Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Sepsis Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Sepsis Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Sepsis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Sepsis Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Sepsis Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Sepsis Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Sepsis Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Sepsis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Sepsis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Sepsis Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Sepsis Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Sepsis Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Sepsis Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Sepsis Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Sepsis Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Sepsis Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Sepsis Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Sepsis Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Sepsis Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Sepsis Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Sepsis Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Sepsis Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Sepsis Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Sepsis Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Sepsis Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Sepsis Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Sepsis Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Sepsis Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Sepsis Drug Sales by Application (2021-2026) & (US$ Million) Table 73. TEVA Company Information Table 74. TEVA Business Overview Table 75. TEVA Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. TEVA Sepsis Drug Product Portfolio Table 77. TEVA Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Sepsis Drug Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novartis Sepsis Drug Product Portfolio Table 87. Novartis Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Sepsis Drug Product Portfolio Table 92. Mylan Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Pfizer Sepsis Drug Product Portfolio Table 97. Pfizer Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Sepsis Drug Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bayer Sepsis Drug Product Portfolio Table 107. Bayer Recent Development Table 108. Shanghai Pharmaceuticals Company Information Table 109. Shanghai Pharmaceuticals Business Overview Table 110. Shanghai Pharmaceuticals Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Shanghai Pharmaceuticals Sepsis Drug Product Portfolio Table 112. Shanghai Pharmaceuticals Recent Development Table 113. NCPC Company Information Table 114. NCPC Business Overview Table 115. NCPC Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. NCPC Sepsis Drug Product Portfolio Table 117. NCPC Recent Development Table 118. Merck & Co Company Information Table 119. Merck & Co Business Overview Table 120. Merck & Co Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Merck & Co Sepsis Drug Product Portfolio Table 122. Merck & Co Recent Development Table 123. Allergan Company Information Table 124. Allergan Business Overview Table 125. Allergan Sepsis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Allergan Sepsis Drug Product Portfolio Table 127. Allergan Recent Development Table 128. North America Sepsis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. North America Sepsis Drug Sales by Country (2021-2026) & (K Units) Table 130. North America Sepsis Drug Sales Market Share by Country (2021-2026) Table 131. North America Sepsis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 132. North America Sepsis Drug Sales Market Share Forecast by Country (2027-2032) Table 133. North America Sepsis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Sepsis Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Sepsis Drug Market Share by Country (2021-2026) Table 136. North America Sepsis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Sepsis Drug Market Share Forecast by Country (2027-2032) Table 138. Europe Sepsis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Europe Sepsis Drug Sales by Country (2021-2026) & (K Units) Table 140. Europe Sepsis Drug Sales Market Share by Country (2021-2026) Table 141. Europe Sepsis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 142. Europe Sepsis Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Sepsis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Sepsis Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Sepsis Drug Market Share by Country (2021-2026) Table 146. Europe Sepsis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Sepsis Drug Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Sepsis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Sepsis Drug Sales by Country (2021-2026) & (K Units) Table 150. Asia-Pacific Sepsis Drug Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Sepsis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 152. Asia-Pacific Sepsis Drug Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Sepsis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Sepsis Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Sepsis Drug Market Share by Country (2021-2026) Table 156. Asia-Pacific Sepsis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Sepsis Drug Market Share Forecast by Country (2027-2032) Table 158. Latin America Sepsis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Latin America Sepsis Drug Sales by Country (2021-2026) & (K Units) Table 160. Latin America Sepsis Drug Sales Market Share by Country (2021-2026) Table 161. Latin America Sepsis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 162. Latin America Sepsis Drug Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Sepsis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Sepsis Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Sepsis Drug Market Share by Country (2021-2026) Table 166. Latin America Sepsis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Sepsis Drug Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Sepsis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Sepsis Drug Sales by Country (2021-2026) & (K Units) Table 170. Middle East and Africa Sepsis Drug Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Sepsis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 172. Middle East and Africa Sepsis Drug Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Sepsis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Sepsis Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Sepsis Drug Market Share by Country (2021-2026) Table 176. Middle East and Africa Sepsis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Sepsis Drug Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Sepsis Drug Distributors List Table 181. Sepsis Drug Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Sepsis Drug Image Figure 2. Global Sepsis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sepsis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Sepsis Drug Sales (2021-2032) & (K Units) Figure 5. Cephalosporin Image Figure 6. Global Cephalosporin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pencillin Image Figure 8. Global Pencillin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Macrolides Image Figure 10. Global Macrolides Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Sepsis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Sepsis Drug Market Share by Type 2025 VS 2032 Figure 15. North America Sepsis Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Sepsis Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Sepsis Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Sepsis Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Sepsis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Sepsis Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Sepsis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Sepsis Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Sepsis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Sepsis Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Sepsis Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Severe Sepsis Image Figure 28. Global Severe Sepsis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Septic Shock Image Figure 30. Global Septic Shock Sales YoY Growth (2021-2032) & (K Units) Figure 31. Sepsis Image Figure 32. Global Sepsis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Sepsis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Sepsis Drug Market Share by Application 2025 VS 2032 Figure 35. North America Sepsis Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Sepsis Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Sepsis Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Sepsis Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Sepsis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Sepsis Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Sepsis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Sepsis Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Sepsis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Sepsis Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Sepsis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Sepsis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Sepsis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Sepsis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sepsis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Sepsis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Sepsis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Sepsis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sepsis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Sepsis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Sepsis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Sepsis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sepsis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Sepsis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Sepsis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Sepsis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sepsis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Sepsis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Sepsis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Sepsis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Sepsis Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Sepsis Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporin
  • Pencillin
  • Macrolides
  • Others
Applications
  • Severe Sepsis
  • Septic Shock
  • Sepsis
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Shanghai Pharmaceuticals
  • NCPC
  • Merck & Co
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sepsis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sepsis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sepsis Drug Market by Type
  6. 1.3.1 Cephalosporin
  7. 1.3.2 Pencillin
  8. 1.3.3 Macrolides
  9. 1.3.4 Others
  10. 1.4 Global Sepsis Drug Market Size by Type
  11. 1.4.1 Global Sepsis Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Sepsis Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Sepsis Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Sepsis Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Sepsis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Sepsis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Sepsis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Sepsis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sepsis Drug Industry Trends
  2. 2.2 Sepsis Drug Industry Drivers
  3. 2.3 Sepsis Drug Industry Opportunities and Challenges
  4. 2.4 Sepsis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sepsis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Sepsis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Sepsis Drug Price (2021-2026)
  4. 3.4 Global Sepsis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sepsis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Sepsis Drug Company, Product Type & Application
  7. 3.7 Global Sepsis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sepsis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sepsis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sepsis Drug Tier 1, Tier 2, and Tier 3
4 Sepsis Drug Regional Status and Outlook
  1. 4.1 Global Sepsis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sepsis Drug Historic Market Size by Region
  3. 4.2.1 Global Sepsis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sepsis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sepsis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sepsis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Sepsis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sepsis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sepsis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sepsis Drug by Application
  1. 5.1 Sepsis Drug Market by Application
  2. 5.1.1 Severe Sepsis
  3. 5.1.2 Septic Shock
  4. 5.1.3 Sepsis
  5. 5.2 Global Sepsis Drug Market Size by Application
  6. 5.2.1 Global Sepsis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sepsis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sepsis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sepsis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sepsis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sepsis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sepsis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sepsis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TEVA
  2. 6.1.1 TEVA Company Information
  3. 6.1.2 TEVA Business Overview
  4. 6.1.3 TEVA Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TEVA Sepsis Drug Product Portfolio
  6. 6.1.5 TEVA Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Sepsis Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Sepsis Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Sepsis Drug Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Sepsis Drug Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Sepsis Drug Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Sepsis Drug Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 Shanghai Pharmaceuticals
  44. 6.8.1 Shanghai Pharmaceuticals Company Information
  45. 6.8.2 Shanghai Pharmaceuticals Business Overview
  46. 6.8.3 Shanghai Pharmaceuticals Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Pharmaceuticals Sepsis Drug Product Portfolio
  48. 6.8.5 Shanghai Pharmaceuticals Recent Developments
  49. 6.9 NCPC
  50. 6.9.1 NCPC Company Information
  51. 6.9.2 NCPC Business Overview
  52. 6.9.3 NCPC Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 NCPC Sepsis Drug Product Portfolio
  54. 6.9.5 NCPC Recent Developments
  55. 6.10 Merck & Co
  56. 6.10.1 Merck & Co Company Information
  57. 6.10.2 Merck & Co Business Overview
  58. 6.10.3 Merck & Co Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck & Co Sepsis Drug Product Portfolio
  60. 6.10.5 Merck & Co Recent Developments
  61. 6.11 Allergan
  62. 6.11.1 Allergan Company Information
  63. 6.11.2 Allergan Business Overview
  64. 6.11.3 Allergan Sepsis Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Allergan Sepsis Drug Product Portfolio
  66. 6.11.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Sepsis Drug Sales by Country
  2. 7.1.1 North America Sepsis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sepsis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Sepsis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sepsis Drug Market Size by Country
  6. 7.2.1 North America Sepsis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sepsis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Sepsis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sepsis Drug Sales by Country
  2. 8.1.1 Europe Sepsis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sepsis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Sepsis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sepsis Drug Market Size by Country
  6. 8.2.1 Europe Sepsis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sepsis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sepsis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sepsis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Sepsis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sepsis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sepsis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sepsis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Sepsis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sepsis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sepsis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sepsis Drug Sales by Country
  2. 10.1.1 South America Sepsis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sepsis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Sepsis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sepsis Drug Market Size by Country
  6. 10.2.1 South America Sepsis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sepsis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Sepsis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sepsis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Sepsis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sepsis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sepsis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sepsis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Sepsis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sepsis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sepsis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sepsis Drug Value Chain Analysis
  2. 12.1.1 Sepsis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sepsis Drug Production Mode & Process
  7. 12.2 Sepsis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sepsis Drug Distributors
  10. 12.2.3 Sepsis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst